ArticleCell death & disease2026

Multi-omics analyses identify EZH2 as a central driver in rhabdomyosarcoma radioresistance and highlight Tazemetostat as an effective radiosensitizer in vitro and in vivo.

Matteo Cassandri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.